USANA HEALTH SCIENCES INC (USNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-03. Amounts in USD.

Revenue TTM

0 350M 700M 1.1B Q3 '25: 862M Q4 '25: 854.5M Q1 '26: 876.2M Q2 '26: 899.2M Q3 '26: 912.7M Q4 '26: 925.3M Q1 '27: 925.9M Q2 '27: 913.4M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Gross Profit TTM

0 250M 500M 750M Q3 '25: 697M Q4 '25: 693.3M Q1 '26: 705.7M Q2 '26: 718.8M Q3 '26: 722.7M Q4 '26: 724.4M Q1 '27: 718.1M Q2 '27: 707.4M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Operating Income TTM

-30M 0 30M 60M 90M Q3 '25: 82.3M Q4 '25: 66.3M Q1 '26: 57.3M Q2 '26: 56.2M Q3 '26: 41.8M Q4 '26: 37.4M Q1 '27: 35.6M Q2 '27: -1.1M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Net Income TTM

-40M -20M 0 20M 40M 60M Q3 '25: 54.3M Q4 '25: 42M Q1 '26: 34.9M Q2 '26: 34.1M Q3 '26: 17M Q4 '26: 10.8M Q1 '27: 8.9M Q2 '27: -22.2M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Cost of Revenue TTM

0 80M 160M 240M Q3 '25: 165M Q4 '25: 161.2M Q1 '26: 170.6M Q2 '26: 180.4M Q3 '26: 190M Q4 '26: 200.9M Q1 '27: 207.8M Q2 '27: 206M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Operating Cash Flow TTM

0 30M 60M 90M Q3 '25: 81.2M Q4 '25: 61M Q1 '26: 58.8M Q2 '26: 63M Q3 '26: 31.5M Q4 '26: 22.3M Q1 '27: 16.6M Q2 '27: 27.7M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Free Cash Flow TTM

0 25M 50M 75M Q3 '25: 65.6M Q4 '25: 50.9M Q1 '26: 49.1M Q2 '26: 51M Q3 '26: 18.7M Q4 '26: 8.5M Q1 '27: 3M Q2 '27: 15.9M Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q1 '25: 19.3M Q2 '25: 19.2M Q3 '25: 19.1M Q1 '26: 19.1M Q2 '26: 18.5M Q3 '26: 18.3M Q1 '27: 18.4M Q2 '27: 18.5M Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26 Q1 '27 Q2 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '25: 2.83 Q4 '25: 2.19 Q1 '26: 1.82 Q2 '26: 1.80 Q3 '26: 0.88 Q4 '26: 0.58 Q1 '27: 0.50 Q2 '27: -1.18 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27 Q2 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.